Thomas Beach
Neuropathology · Sun City, AZNPI 1417292152
Payments from drug & device makers
$1,243,827in general payments, 2019–2025
Across 14 payments — averaging $88,845 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$667K
- GSK$343K
- Avid Radiopharmaceuticals, Inc.$193K
- F. Hoffmann-la Roche AG$38K
- Roche Molecular Systems, Inc.$2K
- Biogen$1K
- plus $170 from 2 others
What the payments were for
- Consulting fees$1,00237%
- Speaking & faculty fees$1,25047%
- Food & beverage$1706%
- Education$2509%
General payments by program year
21
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 3 | $666,800 |
| GSK | 2 | $342,988 |
| Avid Radiopharmaceuticals, Inc. | 3 | $192,993 |
| F. Hoffmann-la Roche AG | 1 | $38,374 |
| Roche Molecular Systems, Inc. | 2 | $1,500 |
| Biogen | 1 | $1,002 |
| Lantheus Medical Imaging, Inc. | 1 | $139 |
| AbbVie | 1 | $31 |
How this compares
Too few neuropathology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Other neuropathology in Sun City
- Naomi RanceTucson$6K
- Ahmed GilaniPhoenix$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.